RIP Sangamo, onshoring with drug manufacturing, and more biotech news from The Readout ...

A judge temporarily blocked federal prosecutors in Texas from getting access to the medical records of transgender patients ...

Regenxbio plans to submit its Duchenne gene therapy for FDA approval, just a month after it said that regulators wanted to ...

The Justice Department has charged a Texas doctor in an $89 million health care fraud scheme, accusing him of billing ...

The FDA told wearable maker Whoop last week that it would not take further enforcement action over the company's blood ...

With the right structure, Americans will roll up their sleeves, do the science, and trust the result,” Manoush Zomorodi ...

Relatively speaking, the least controversial application of human embryo genome editing is to use it to try to prevent ...

Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis ...

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on ...

Eli Lilly is investing in a small startup developing a medication to spur hair growth, and potentially also treat endometriosis.

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and ...

Exclusive: STAT has learned that Eli Lilly and the FDA allowed a 79-year-old to gain extraordinary access to an experimental ...